Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025Caidya, a leading global, mid-sized CRO, today announced the appointment of Brandon Pallott as its new chief commercial officer (CCO). In this role, he will focus on implementing transformative commercial strategies to ensure the organization not only adapts to the evolving market landscape but also leads the industry forward. On the heels of Caidya’s recent investment of $165M from Rubicon Founders, the company is poised to continue and improve its ability to deliver exceptional outcomes for the sponsors and patients.

A collaborative and results-driven visionary executive, Brandon has successfully led high-performing, cross-functional teams in commercial, business development, and revenue-generating roles for more than 20 years. With deep expertise in crafting and executing go-to-market strategies across clinical and commercial arenas in the life sciences industry, he has consistently demonstrated his ability to build strategic partnerships, drive innovative initiatives, and expand markets to achieve commercial excellence.

Caidya’s Chief Executive Officer, Barbara Lopez Kunz, said, “I’m thrilled to have Brandon join our leadership team, and I’m confident in his ability to guide us in elevating our clients’ experience — from the very first contact to every touchpoint thereafter.”

“I am beyond excited to join Caidya at the cusp of this next phase of our growth,” said Pallott. “And I’m eager to start working with our talented commercial and operational teams as we collaborate with biopharma partners to help them bring treatments to patients.”

For more information about Caidya and its services, please visit www.caidya.com.

About Caidya
Caidya is a global, mid-sized clinical research organization (CRO) dedicated to advancing healthcare innovation and partnering with biopharma sponsors to bring innovative therapies for unmet medical conditions to our global community. With full-service capabilities and a strategic footprint in 23 countries and regions, our global network provides broad access to diverse patient populations across the Americas, Europe, and APAC. Caidya’s in-depth therapeutic and operational expertise spans oncology and hematology, rare and pediatric diseases as well as other fast-growing therapeutic areas where we help our biopharma partners conduct studies with greater efficiency and confidence.

Caidya delivers comprehensive clinical trial services from regulatory strategy and submissions, medical affairs, clinical operations, data management, biometrics, pharmacovigilance, and quality management, through post-approval surveillance. Our data-driven, evidence-based decision making ensures the highest quality standards across all stages of the drug development process.

Media Contacts:
Miron Lila
Senior VP, Head of Corporate Development and Investor Relations, Caidya
[email protected]

Roger Boutin
VP, Corporate Marketing, Caidya
[email protected]

You might also be interested in

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

01/13/25

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global mi...

Read more

Caidya Announces Leadership Transition: Barbara Lopez Kunz Named CEO

07/22/24

Raleigh, N.C., July 22, 2024 – Caidya, a leading global pr...

Read more

Caidya Achieves Medidata Rave TSDV Accreditation, Enhancing Clinical Trial Efficiency and Data Integrity

06/12/24

Raleigh, N.C., June 12, 2024 – Caidya, a leading provider ...

Read more
Leading a new way

The latest from Caidya

Explore our news and updates as we liberate the clinical research process.

17th Annual Outsourcing in Clinical Trials West Coast 2025

11th February 2025 to 12th February 2025
Hyatt Regency San Francisco Airport, Burlingame, CA, USA

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Skip to toolbar